Provided by Tiger Trade Technology Pte. Ltd.

INmune Bio Inc

2.31
-0.0250-1.07%
Volume:222.91K
Turnover:506.07K
Market Cap:63.97M
PE:-3.32
High:2.33
Open:2.32
Low:2.21
Close:2.33
52wk High:2.50
52wk Low:1.09
Shares:27.75M
Float Shares:23.19M
Volume Ratio:1.07
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6937
EPS(LYR):-1.8600
ROE:-74.82%
ROA:-39.12%
PB:3.14
PE(LYR):-1.24

Loading ...

Inmune Bio’s Xpro1595 Prevents Brain-injury-induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-reviewed Preclinical Study

THOMSON REUTERS
·
Jul 15

INmune Bio And 2 Other Promising Penny Stocks To Consider

Simply Wall St.
·
Jul 14

Inmune Bio Says Phase 2 Xpro Trial Shows Significant Week 24 MRI Myelin Benefit in Early Alzheimer’s Patients

Reuters
·
Jul 09

Sector Update: Healthcare Stocks Edge Higher Premarket Wednesday

MT Newswires Live
·
Jul 01

INmune Bio Files US Patent Application for CORDStrom Cell Therapy Platform

MT Newswires Live
·
Jul 01

INmune Bio advances CORDStrom platform patent application in the U.S.

TIPRANKS
·
Jul 01

Inmune Bio Says Holders Exercise 647,112 Warrants at $1.4 Per Share Under Inducement Offer

Reuters
·
Jul 01

INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion

GlobeNewswire
·
Jul 01

Inmune Bio Wins MHRA Pediatric Plan Approval for Ebstrocel in RDEB

Reuters
·
Jun 25

Inmune Bio Inc. Achieves Mhra Approval of Pip for Cordstrom™

THOMSON REUTERS
·
Jun 25

Inmune Bio - UK Mhra Approves Pediatric Investigation Plan for Ebstrocel for Rdeb

THOMSON REUTERS
·
Jun 25

Inmune Bio - Preparing for Maa Submission and Final Manufacturing for Ebstrocel

THOMSON REUTERS
·
Jun 25

INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™

GlobeNewswire
·
Jun 25

Analysts Are Bullish on These Healthcare Stocks: Inmune Bio (INMB), AbSci (ABSI)

TIPRANKS
·
Jun 25

INmune Bio announces MHRA alignment in pre-MAA CORDStrom meeting

TIPRANKS
·
Jun 24

INmune Bio's CORDStrom Gets Written Alignment on UK Conditional Marketing Authorization Application

MT Newswires Live
·
Jun 23

INmune Bio - Mhra Affirms INmune Bio's Pooled-Donor Approach as Acceptable

THOMSON REUTERS
·
Jun 23

INmune Bio: Advancing Final Commercial Manufacturing Validation Activities & Dossier Compilation to Support Planned UK Submission

THOMSON REUTERS
·
Jun 23

INmune Bio Receives Mhra Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for Cordstrom™ in Rdeb

THOMSON REUTERS
·
Jun 23

INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB

GlobeNewswire
·
Jun 23